Abstract Details

Title Pilot Phase I/II Clinical Trial with Autologous Mesenchymal Stem Cells in Patients with Multiple Sclerosis and Amyotrophic Lateral Sclerosis

Topic MS and Related Diseases

Presentation(s) (-)

Poster/Presentation
Number 006

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Dimitrios Karussis, MD, PhD (Hadassah HMO)	Prof. Karussis has nothing to disclose.
Clementine Karageorgiou, MD (Neurological Institute of Athens)	The institution of Dr. Karageorgiou has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for GENESIS PHARMA. The institution of Dr. Karageorgiou has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for TEVA-SPECIFAR.
	No disclosure on file
	No disclosure on file
Adi Vaknin-Dembinsky, MD	No disclosure on file
	No disclosure on file
Ibrahim Kassis, PhD (Hadassah)	No disclosure on file
	No disclosure on file
Panayiota Petrou	No disclosure on file
	No disclosure on file
	No disclosure on file

��ɫ��